BMO Capital Turns Neutral on Emerson Electric (EMR) Despite Automation Shift

Emerson Electric Co. (NYSE:EMR) is included among the 13 Best Diversified Dividend Stocks to Buy Right Now.

BMO Capital Turns Neutral on Emerson Electric (EMR) Despite Automation Shift

On March 27, BMO Capital analyst Daniel DiCicco initiated coverage of Emerson Electric Co. (NYSE:EMR) with a Market Perform rating. It also set a $150 price target on the stock. The firm said Emerson has repositioned itself as a global automation and industrial software company. At the same time, BMO noted it does not see meaningful upside potential to estimates in 2026.

During the fiscal Q1 2026 earnings call, Surendralal Karsanbhai, President, CEO, and Director, marked his fifth year in the role and pointed to the company’s continued shift toward becoming what he described as the world’s leading automation company. He said the business is now aligned with long-term structural trends that, in his view, are expected to support strong growth well into the future. He also laid out the company’s plan for returning value to shareholders. He said Emerson intends to distribute $10 billion, or about 70% of its cumulative cash, through $6 billion in share buybacks and $4 billion in dividends.

Karsanbhai said demand trends remained solid, with underlying orders up 9%. He noted that customers are committing more capital to longer-cycle projects across key growth areas. Activity picked up across North America, India, and the Middle East and Africa. At the segment level, he said Test & Measurement posted an 11% year-over-year increase, while the Ovation business grew 20%, supported by steady demand tied to the power sector.

Emerson Electric Co. (NYSE:EMR) operates as a global technology and software company, providing solutions across a broad set of end markets. The company is organized into seven segments under two main business groups, including Intelligent Devices and Software and Control.

While we acknowledge the risk and potential of EMR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than EMR and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Dividend Stock Portfolio for Income: 15 Stocks to Invest In and Dividend Capture Strategy: 14 High Yield Stocks to Buy in April

Disclosure: None. Follow Insider Monkey on Google News.